MUSE® drug delivery device for erectile dysfunction Gill Higgins Newsletter Article 04 February 2013 Pages: 3 - 4
Home antineoplastic therapy reduces costs and improves QOL Newsletter Article 04 February 2013 Pages: 6 - 6
Use study criteria to select ACE inhibitor candidates Newsletter Article 04 February 2013 Pages: 6 - 6
Diagnosis poor predictor of use and cost of mental health services Newsletter Article 04 February 2013 Pages: 6 - 6
Underuse of antiasthmatics leads to multiple ED visits Newsletter Article 04 February 2013 Pages: 7 - 7
Lamivudine is well tolerated in advanced HIV infection Newsletter Article 04 February 2013 Pages: 7 - 7
Antipsychotic efficacy of ICI-204636 not yet optimised Newsletter Article 04 February 2013 Pages: 8 - 8
Filling the gaps in therapy for pulmonary fibrosis Rodger Hall Newsletter Article 04 February 2013 Pages: 9 - 10
Acute leukaemia in the elderly: G-CSF and GM-CSF disappoint Newsletter Article 04 February 2013 Pages: 13 - 13
No advantage with interferon-α-2c in advanced colorectal cancer Newsletter Article 04 February 2013 Pages: 14 - 14
Combination treatment better in severe/recurrent DVT Newsletter Article 04 February 2013 Pages: 15 - 15
Short- or long-term oral anticoagulant therapy for venous thrombosis? Newsletter Article 04 February 2013 Pages: 15 - 15
NSAID warning, and a look to the future for osteoarthritis Gill Higgins Newsletter Article 04 February 2013 Pages: 16 - 18
Simplifying management after intracoronary stent implantation Newsletter Article 04 February 2013 Pages: 18 - 18
Surfactant beneficial in neonatal respiratory distress syndrome Newsletter Article 04 February 2013 Pages: 19 - 19
Acute MI: enhancing myocardial salvage with magnesium sulfate? Newsletter Article 04 February 2013 Pages: 19 - 19
High-dose rapid oral loading of amiodarone: caution required in CHF Newsletter Article 04 February 2013 Pages: 20 - 20
Somatostatin analogues: new prospects for cholangiocarcinoma treatment? Newsletter Article 04 February 2013 Pages: 20 - 20